Talphera’s Promising Prospects: Buy Rating Affirmed Amidst Strategic Advancements in Anticoagulant Development
Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...
TCTMD14h
Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F
The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.
Le Lézard12h
NYU Langone Heart's Leading Cardiologists Present Latest Research at the American Heart Association's Scientific Sessions 2024
Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...